Director/PDMR Shareholding - Replacement

RNS Number : 6825B

Genedrive PLC

05 April 2017

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them - Replacement

The following amendments have been made to the 'Director/PDMR Shareholding' announcement released today at 11:17am under RNS No 6708B.

50,000 options were granted to each of Allan Brown and Gino Miele and not 117,647.

All other details remain unchanged.

The full amended text is shown below,

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has granted share options ("Options") to certain of its directors and senior management to acquire a total of 632,884 ordinary shares of 1.5p each in the capital of the Company under the Company's Share Option Scheme.

The Options have been granted with an exercise price equal to the close price on the day before grant and vest after a period of three years. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1.   David Budd 2.   Allan Brown 3.   Gino Miele
2.	Reason for the notification
a.	Position/status	1.   Chief Executive Officer 2.   Chief Operating Officer 3.   R&D Director
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	genedrive plc
b.	LEI	N/A
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Options over ordinary shares of 1.5 pence each
b.	Nature of the transaction	Grant of options pursuant to and in accordance with the terms of the Company's Share Option Scheme dated 28 November 2007.
c.	Price(s) and volume(s)	Price(s) Option price(s) Volume(s) David Budd 42.5p 397,590 Allan Brown 42.5p 50,000 Gino Miele 42.5p 50,000
d.	Aggregated information ·      Aggregated volume ·      Price	N/A
e.	Date of the transaction	2016-04-04; UTC time
f.	Place of the transaction	Outside trading venue - shares to be admitted to AIM market of London Stock Exchange plc on exercise of options

For further details please contact:

genedrive plc	[phone]
David Budd: CEO
Matthew Fowler: CFO
Peel Hunt LLP	[phone]
James Steel
Oliver Jackson
Consilium Strategic Communications	[phone]
Chris Gardner
Matthew Neal
Laura Thornton
[e-mail]

 

END

 

 

DSHSSLFFIFWSEDL